CRH vs Dow
Add, change or remove companies; up to four.
KIRAβs take AI analyst
I put CRH and Dow side by side, using each oneβs latest annual report. Here is what stands out:
- Dow is the larger business, with $40.0B of revenue in fiscal 2025 against $37.4B for CRH.
- CRH grew revenue faster (5.3%, against β7.0%).
- CRH turned more of its sales into free cash flow (7.8% FCF margin, against β3.6%).
- CRH earned a higher return on the capital invested in it (11.8%, against β4.1%).
Who comes out ahead
Of the 10 measures where higher (or lower) is clearly better, how many each company leads.
CRH
CRH
10/10
Revenue growth5-year growthGross marginNet marginFCF marginReturn on capitalReturn on equityPiotroski F-scoreNet debt / EBITDAShare count change
Dow
DOW
0/10
Side by side
Best in the row
| Latest fiscal year | CRH FY25 | DOW FY25 |
|---|---|---|
| Size | ||
| Market cap | $57.1B | $24.5B |
| Revenue | $37.4B | $40.0B |
| Free cash flow | $2.9B | β$1.4B |
| Net income | $3.8B | β$2.6B |
| Growth | ||
| Revenue growth | 5.3% | β7.0% |
| 5-year growth | 7.7% | 0.7% |
| Share count change | β1.8% | 0.9% |
| Profitability | ||
| Gross margin | 36.1% | 6.3% |
| Operating margin | 14.5% | β |
| Net margin | 10.0% | β6.6% |
| FCF margin | 7.8% | β3.6% |
| Return on capital | 11.8% | β4.1% |
| Return on equity | 16.5% | β15.7% |
| Balance sheet | ||
| Net debt | $14.1B | $14.3B |
| Net debt / EBITDA | 1.9x | 12.0x |
| Dividends and buybacks | $1.2B | $1.5B |
| Valuation & quality | ||
| P/E | 15.1x | β |
| Piotroski F-score | 7 | 3 |
Ten years
Revenue
FY16
CRH β
DOW β
FY17
CRH β
DOW $43.7B
FY18
CRH $27.4B
DOW $49.6B
FY19
CRH $28.1B
DOW $43.0B
FY20
CRH $25.9B
DOW $38.5B
FY21
CRH $29.2B
DOW $55.0B
FY22
CRH $32.7B
DOW $56.9B
FY23
CRH $34.9B
DOW $44.6B
FY24
CRH $35.6B
DOW $43.0B
FY25
CRH $37.4B
DOW $40.0B
CRH
DOW
Operating margin
FY16
CRH β
DOW β
FY17
CRH β
DOW β
FY18
CRH 8.9%
DOW β
FY19
CRH 9.9%
DOW β
FY20
CRH 7.8%
DOW β
FY21
CRH 11.4%
DOW β
FY22
CRH 11.6%
DOW β
FY23
CRH 12.0%
DOW β
FY24
CRH 13.9%
DOW β
FY25
CRH 14.5%
DOW β
CRH
DOW
Free cash flow
FY16
CRH β
DOW β
FY17
CRH β
DOW β$7.7B
FY18
CRH $922M
DOW $2.2B
FY19
CRH $2.5B
DOW $4.0B
FY20
CRH $2.9B
DOW $5.0B
FY21
CRH $2.4B
DOW $5.5B
FY22
CRH $2.3B
DOW $5.7B
FY23
CRH $3.2B
DOW $2.8B
FY24
CRH $2.4B
DOW β$26.0M
FY25
CRH $2.9B
DOW β$1.4B
CRH
DOW
Return on capital
FY16
CRH β
DOW β
FY17
CRH β
DOW β
FY18
CRH β
DOW β
FY19
CRH 6.5%
DOW β0.6%
FY20
CRH 5.0%
DOW 6.6%
FY21
CRH 10.3%
DOW 24.6%
FY22
CRH 11.3%
DOW 15.9%
FY23
CRH 12.1%
DOW 4.3%
FY24
CRH 12.7%
DOW 5.7%
FY25
CRH 11.8%
DOW β4.1%
CRH
DOW
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.